/Investor DB

Section 32 — 2022 Investments

6 investments dated 2022 · listed companies and verified rows first · show all

BigHat Biosciencesbighatbio.comin𝕏Jul 2022 · $75M

Big Hat Bio develops therapeutics under development across multiple programs.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Peyton Greenside(Founder)inMark DePristo(Founder)inMark DePristo Peyton Greenside(Founder)Theresa Tribble(Founder)Andrew Conrad(Director)

BoardFrancisco Gimenez(Director)in

Co-investors8VCAndreessen HorowitzBOLD LongevityCatalio Capital Management, LPFlucas VenturesGaingels+16 more

Inworld AIinworld.aiin𝕏Aug 2022

Inworld AI provides a full-duplex audio streaming platform that enables real-time conversational AI interactions with intelligent turn-taking, function calling, and multi-model routing capabilities for developers building conversational applications.

AI & Machine LearningDeveloper ToolsMountain View, US

Ilya Gelfenbeyn(Founder)inKylan Gibbs(Founder)inMichael Ermolenko(Founder)in

Co-investorsA-Force VenturesBitkraft Esports VenturesBrave CapitalCRV (Charles River Ventures)Dentsu VenturesDisney Accelerator+16 more

MOMA Therapeuticsmomatx.comin𝕏May 2022 · $150M

A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.

Biotech

Timur Yusufzai(Founder)inAsit Parikh(Chief Executive Officer)in

Co-investorsLifeSci Venture PartnersNextech InvestThird Rock VenturesAlexandriaCasdin CapitalCreacion Ventures+4 more

Nested Therapeuticsnestedtx.comin𝕏Oct 2022

Nested Therapeutics is a precision oncology company developing small-molecule cancer therapeutics by identifying overlooked driver mutations and novel binding pockets through a drug discovery platform combining genomics, computational biophysics, machine learning, and chemical biology.

AI & Machine LearningBiotechHealthtech

Arvin Dar(Co-founder & Board Observer)inKevan Shokat(Scientific Co-founder)Klaus Hoeflich(Co-founder & former Chief Scientific Officer)inDarrin Miles(Chief Executive Officer)inPhilip Komarnitsky(Chief Medical Officer)inTanja Weber(Chief Business Officer)in

Co-investorsVersant VenturesForesite CapitalSixty Degree CapitalCowen Healthcare InvestmentsGoldman Sachs

ONIoni.bioin𝕏Jan 2022 · $75M

ONI develops the Nanoimager, an automated super-resolution imaging system.

BiotechDeep TechHardwareMedical DevicesOxford, GB

Paul Scagnetti(Chief Executive Officer)in

Co-investorsAnjostARCH Venture PartnersArtis VenturesFuture Planet CapitalOxford Technology ManagementVertical Venture Partners+6 more

Sandbox AQsandboxaq.comin𝕏Mar 2022

SandboxAQ combines artificial intelligence and quantum technology to address complex industrial challenges.

AI & Machine LearningDeep TechQuantum Computing

Jack Hidary(Founder)in

BoardSergey Brin(Founder)

Co-investorsAllianz XAvant Global LLCBenhamou Global VenturesBGVBreyer CapitalElaia+15 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.